Hyfusin Group to Seek 20% Issue Mandate, 10% Buy-Back Authority and M&A Revamp at 5 June AGM

Bulletin Express
04/22

Hyfusin Group Holdings Limited (Hyfusin Group, 08512) has dispatched a circular dated 23 April 2026 convening its annual general meeting (AGM) for 5 June 2026 in Hong Kong. Key resolutions include refreshed share mandates, board re-elections and a comprehensive update to the company’s constitutional documents.

Mandates on Share Capital • General Issuance: Directors will request authority to allot, issue or deal with up to 20% of the company’s issued share capital (excluding any treasury shares) as at the AGM date. Based on the 918.50 million shares outstanding on the 15 April 2026 latest practicable date, the mandate would cover up to 183.70 million shares. • Share Repurchase: A separate mandate will permit repurchases of up to 10% of issued shares, or 91.85 million shares. Shares bought back may be cancelled or held in treasury under the proposed new Articles. • Extension Option: Subject to both mandates being approved, the board may extend the issuance limit by the number of shares repurchased, potentially raising the effective issuance headroom to 30% of current issued capital.

Governance Matters • Director Elections: Executive Director and CEO Mr Wong Man Chit and Independent Non-Executive Director Mr Ho Chi Wai will retire by rotation and stand for re-election. • Auditor: Re-appointment of BDO Limited and authorisation for directors to fix its remuneration will be voted on. • Constitutional Upgrade: Shareholders will consider adopting a third amended and restated Memorandum & Articles of Association. Key changes introduce explicit provisions for electronic, hybrid and virtual meetings; enable holding of treasury shares; align with the HKEX’s paperless listing framework; and incorporate housekeeping updates.

Key Dates • Register of members closure: 29 May–5 June 2026 (both days inclusive). • Proxy lodgement deadline: 3:00 p.m., 3 June 2026. • Record date for AGM voting: 5 June 2026.

The board emphasises that it has no immediate plans to issue new shares or undertake share buy-backs following approval of the proposed mandates.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10